ARTICLE: Catalyzing the Development of Life-Saving Cancer Treatments
This article dives into the unique design strategies of a high-rise, cGMP facility that improves the efficiency in the scientific workplace.
Located on Penn Medicine’s campus in Philadelphia amidst both clinical care and laboratory facilities, the 30,000 sf Center for Advanced Cellular Therapies (CACT) brings together Penn Medicine’s intellectual resources combined with pharmaceutical industry leader Novartis with the mutual goal of expediting the development of novel gene therapies for complex diseases of all kinds including cancer.
The center employs 100 highly-specialized professionals working across 6,300 sf of clean room space specially designed for cell engineering and 24,000 sf of laboratory and cell therapy manufacturing space with the capacity to manufacture cellular therapies for up to 400 patients per year.
To download the whitepaper, please fill out the form below: